Receptor EphA2 activation with ephrinA1 suppresses growth of malignant mesothelioma (MM)

被引：43

作者：

Nasreen, Najmunnisa ^{[1
]}

Mohammed, Kamal A. ^{[1
]}

Lai, Yimu ^{[1
]}

Antony, Veena B. ^{[1
]}

机构：

[1] Univ Florida, Dept Med, Div Pulm & Crit Care Med, Gainesville, FL 32611 USA

来源：

CANCER LETTERS | 2007年 / 258卷 / 02期

关键词：

EphA2; EphrinA1; malignant mesothelioma; receptor tyrosine kinase; proliferation; ERK1/2;

D O I：

10.1016/j.canlet.2007.09.005

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The objective of this study was to understand the possible mechanisms of activation of receptor EphA2 by its ligand ephrinA1 in malignant mesothelioma cell (MMC) growth. Activation of receptor EphA2 by its ligand ephrinA1 triggered the phosphorylation of EphA2. Ligand activation of EphA2 also induced phosphorylation of ERK1/2 and significantly decreased MMC proliferation. Ligand activated and ephrinA1 vector (pcDNA/EFNA1) transfected MMC demonstrated decreased clonal growth in 3-D matrigels when compared to resting MMC. These studies suggest that EphA2 activation by its ligand ephrinA1 transmits intracellular signals from cell membrane to nucleus via ERK1/2 signaling cascade and inhibits MM growth. Published by Elsevier Ireland Ltd.

引用

页码：215 / 222

页数：8

共 42 条

[1] Requirement of the MAP kinase cascade for cell cycle progression and differentiation of human intestinal cells [J].

Aliaga, JC ;

Deschênes, C ;

Beaulieu, JF ;

Calvo, EL ;

Rivard, N .

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 1999, 277 (03) :G631-G641

[2] EphrinA1-induced cytoskeletal re-organization requires FAK and p130cas [J].

Carter, N ;

Nakamoto, T ;

Hirai, H ;

Hunter, T .

NATURE CELL BIOLOGY, 2002, 4 (08) :565-573

[3] MALIGNANT PLEURAL MESOTHELIOMA AND EPIDERMAL GROWTH-FACTOR RECEPTOR (EGF-R) - RELATIONSHIP OF EGF-R WITH HISTOLOGY AND SURVIVAL USING FIXED PARAFFIN EMBEDDED TISSUE AND THE F4, MONOCLONAL-ANTIBODY [J].

DAZZI, H ;

HASLETON, PS ;

THATCHER, N ;

WILKES, S ;

SWINDELL, R ;

CHATTERJEE, AK .

BRITISH JOURNAL OF CANCER, 1990, 61 (06) :924-926

[4] Ligation of EphA2 by Ephrin A1-Fc inhibits pancreatic adenocarcinoma cellular invasiveness [J].

Duxbury, MS ;

Ito, H ;

Zinner, MJ ;

Ashley, SW ;

Whang, EE .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 320 (04) :1096-1102

[5] ABNORMAL PROTEIN-TYROSINE KINASE GENE-EXPRESSION DURING MELANOMA PROGRESSION AND METASTASIS [J].

EASTY, DJ ;

HERLYN, M ;

BENNETT, DC .

INTERNATIONAL JOURNAL OF CANCER, 1995, 60 (01) :129-136

[6] Downregulation of the Ras-mitogen-activated protein kinase pathway by the EphB2 receptor tyrosine kinase is required for ephrin-induced neurite retraction [J].

Elowe, S ;

Holland, SJ ;

Kulkarni, S ;

Pawson, T .

MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (21) :7429-7441

[7] Repelling class discrimination: ephrin-A5 binds to and activates EphB2 receptor signaling [J].

Himanen, JP ;

Chumley, MJ ;

Lackmann, M ;

Li, C ;

Barton, WA ;

Jeffrey, PD ;

Vearing, C ;

Geleick, D ;

Feldheim, DA ;

Boyd, AW ;

Henkemeyer, M ;

Nikolov, DB .

NATURE NEUROSCIENCE, 2004, 7 (05) :501-509

[8] Cell-contact-dependent signalling in axon growth and guidance:: Eph receptor tyrosine kinases and receptor protein tyrosine phosphatase β [J].

Holland, SJ ;

Peles, E ;

Pawson, T ;

Schlessinger, J .

CURRENT OPINION IN NEUROBIOLOGY, 1998, 8 (01) :117-127

[9]

Jin Mu-lan, 2006, Zhonghua Bing Li Xue Za Zhi, V35, P602

[10] Overexpression and functional alterations of the EphA2 tyrosine kinase in cancer [J].

Kinch, MS ;

Carles-Kinch, K .

CLINICAL & EXPERIMENTAL METASTASIS, 2003, 20 (01) :59-68

← 1 2 3 4 5 →